Skip to contentJ
JRSIS HEALTH CARE Corp
J
JRSSJRSIS HEALTH CARE Corp Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$12.69M$12.69Mderived+48.3% vs Q4 2019 Net Income$2.08M$2.08MderivedN/M vs Q4 2019 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
JRSIS HEALTH CARE Corp · CIK 1597892 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$2,687,372+143.2% Operating Cash Flowderived$3,135,195+4.2% Free Cash Flowderived-$457,131N/M Margins · derivedOperating margin21.2%+8.3 pt vs Q4 2019
Net margin16.4%+27.0 pt vs Q4 2019
ended Dec 31, 2020 · filed Apr 15, 2021 · 105 d after period end